📊 Score Breakdown
Offering Ability
20
Cash Runway
95
Float Risk
62
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
51%
💰 Capital Raise
55%
• Critical: only 2.2 months cash remaining
📉 Score Deterioration
50%
• Score rose 38 points recently (worsening)
• Score in HIGH risk zone (65/100)
🔄 Reverse Split
45%
• 50-day avg $1.04 approaching $1 threshold
• Only 2 months cash — financial pressure
💹 Market Data
Market Cap$1.55M
Shares Outstanding1.82M
Float400.9K
Cash$188.4K
Debt$719.1K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 32.2% shares (2025Q4 vs prior)
3 institutional holders · 11.9K shares
#1
BANK OF AMERICA CORP /DE/
8.6K shares
#2
CITIGROUP INC
2.3K shares
#3
UBS Group AG
945 shares
📉 Short Interest
Short Interest15.5K
Days to Cover1.0
% of Float3.9%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
No recent SEC insights
📰 Recent News
No recent news
🔬 More Research for IBG
📊 IBG FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 IBG Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.